# EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair

> **NCT01801124** · PHASE4 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 13 (actual)

## Conditions studied

- Hernia

## Interventions

- **DRUG:** EXPAREL

## Key facts

- **NCT ID:** NCT01801124
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801124, "EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01801124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*